NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

20.50

-1.34 (-6.14%)

At close: Jun 11, 2025, 4:00 PM

21.00

+0.50 (2.44%)

Pre-market: Jun 12, 2025, 7:12 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Transformative Therapies for Cardio-metabolic Diseases	45.56M	Log In	Log In
Transformative Therapies for Cardio-metabolic Diseases Growth	223.37%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Italy	45.56M	Log In	Log In
Italy Growth	223.37%	Log In	Log In